Data Updated for Q4 2018
CPT Code: 90686
Description: Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use
Status Code
X
Statutory Exclusion. These codes represent an item or service that is not in the statutory definition of “physician services” for fee schedule payment purposes. No RVUS or payment amounts are shown for these codes,
Global Days
XXX
The global concept does not apply to the code.
Medicare RUVs and Fees
Work RVU – 0.00
Malpractice RVU – 0.00
Facility RVU – 0.00
Non-Facility RVU – 0.00
Facility Total RVU – 0.00
Non-Facility Total RVU – 0.00
Medicare National Facility Total Payment – $0
Medicare National Non-Facility Total Payment – $0
Bundling Information
Includes
36591, 36592
Included In
No Incuded In Edits for this Code
Mutually Exclusive
90630, 90654, 90656, 90672, 90674, 90682, 90685, 90756, Q2035, Q2036, Q2037, Q2038, Q2039
If you get stuck finding the right Code, take a look at our 5 Ways to Find the Most Appropriate CPT Code.
Related CPT Codes
CPT Code | Description |
---|---|
90620 | Meningococcal recombinant protein and outer membrane vesicle vaccine, serogroup B (MenB-4C), 2 dose schedule, for intramuscular use |
90620 | Meningococcal recombinant protein and outer membrane vesicle vaccine, serogroup B (MenB-4C), 2 dose schedule, for intramuscular use |
90621 | Meningococcal recombinant lipoprotein vaccine, serogroup B (MenB-FHbp), 2 or 3 dose schedule, for intramuscular use |
90625 | Cholera vaccine, live, adult dosage, 1 dose schedule, for oral use |
90630 | Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, for intradermal use |
90632 | Hepatitis A vaccine (HepA), adult dosage, for intramuscular use |
90633 | Hepatitis A vaccine (HepA), pediatric/adolescent dosage-2 dose schedule, for intramuscular use |
90634 | Hepatitis A vaccine (HepA), pediatric/adolescent dosage-3 dose schedule, for intramuscular use |
90636 | Hepatitis A and hepatitis B vaccine (HepA-HepB), adult dosage, for intramuscular use |
90644 | Meningococcal conjugate vaccine, serogroups C & Y and Haemophilus influenzae type b vaccine (Hib-MenCY), 4 dose schedule, when administered to children 6 weeks-18 months of age, for intramuscular use |
90647 | Haemophilus influenzae type b vaccine (Hib), PRP-OMP conjugate, 3 dose schedule, for intramuscular use |
90648 | Haemophilus influenzae type b vaccine (Hib), PRP-T conjugate, 4 dose schedule, for intramuscular use |
90649 | Human Papillomavirus vaccine, types 6, 11, 16, 18, quadrivalent (4vHPV), 3 dose schedule, for intramuscular use |
90650 | Human Papillomavirus vaccine, types 16, 18, bivalent (2vHPV), 3 dose schedule, for intramuscular use |
90651 | Human Papillomavirus vaccine types 6, 11, 16, 18, 31, 33, 45, 52, 58, nonavalent (9vHPV), 2 or 3 dose schedule, for intramuscular use |
90653 | Influenza vaccine, inactivated (IIV), subunit, adjuvanted, for intramuscular use |
90654 | Influenza virus vaccine, trivalent (IIV3), split virus, preservative-free, for intradermal use |
90655 | Influenza virus vaccine, trivalent (IIV3), split virus, preservative free, 0.25 mL dosage, for intramuscular use |
90656 | Influenza virus vaccine, trivalent (IIV3), split virus, preservative free, 0.5 mL dosage, for intramuscular use |
90657 | Influenza virus vaccine, trivalent (IIV3), split virus, 0.25 mL dosage, for intramuscular use |
90658 | Influenza virus vaccine, trivalent (IIV3), split virus, 0.5 mL dosage, for intramuscular use |
90660 | Influenza virus vaccine, trivalent, live (LAIV3), for intranasal use |
90661 | Influenza virus vaccine, trivalent (ccIIV3), derived from cell cultures, subunit, preservative and antibiotic free, 0.5 mL dosage, for intramuscular use |
90662 | Influenza virus vaccine (IIV), split virus, preservative free, enhanced immunogenicity via increased antigen content, for intramuscular use |
90664 | Influenza virus vaccine, live (LAIV), pandemic formulation, for intranasal use |
90666 | Influenza virus vaccine (IIV), pandemic formulation, split virus, preservative free, for intramuscular use |
90667 | Influenza virus vaccine (IIV), pandemic formulation, split virus, adjuvanted, for intramuscular use |
90668 | Influenza virus vaccine (IIV), pandemic formulation, split virus, for intramuscular use |
90670 | Pneumococcal conjugate vaccine, 13 valent (PCV13), for intramuscular use |
90672 | Influenza virus vaccine, quadrivalent, live (LAIV4), for intranasal use |
90673 | Influenza virus vaccine, trivalent (RIV3), derived from recombinant DNA, hemagglutinin (HA) protein only, preservative and antibiotic free, for intramuscular use |
90674 | Influenza virus vaccine, quadrivalent (ccIIV4), derived from cell cultures, subunit, preservative and antibiotic free, 0.5 mL dosage, for intramuscular use |
90675 | Rabies vaccine, for intramuscular use |
90676 | Rabies vaccine, for intradermal use |
90680 | Rotavirus vaccine, pentavalent (RV5), 3 dose schedule, live, for oral use |
90681 | Rotavirus vaccine, human, attenuated (RV1), 2 dose schedule, live, for oral use |
90682 | Influenza virus vaccine, quadrivalent (RIV4), derived from recombinant DNA, hemagglutinin (HA) protein only, preservative and antibiotic free, for intramuscular use |
90685 | Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.25 mL dosage, for intramuscular use |
90686 | Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use |
90687 | Influenza virus vaccine, quadrivalent (IIV4), split virus, 0.25 mL dosage, for intramuscular use |
90688 | Influenza virus vaccine, quadrivalent (IIV4), split virus, 0.5 mL dosage, for intramuscular use |
90690 | Typhoid vaccine, live, oral |
90691 | Typhoid vaccine, Vi capsular polysaccharide (ViCPs), for intramuscular use |
90696 | Diphtheria, tetanus toxoids, acellular pertussis vaccine and inactivated poliovirus vaccine (DTaP-IPV), when administered to children 4 through 6 years of age, for intramuscular use |
90697 | Diphtheria, tetanus toxoids, acellular pertussis vaccine, inactivated poliovirus vaccine, Haemophilus influenzae type b PRP-OMP conjugate vaccine, and hepatitis B vaccine (DTaP-IPV-Hib-HepB), for intramuscular use |
90698 | Diphtheria, tetanus toxoids, acellular pertussis vaccine, Haemophilus influenzae type b, and inactivated poliovirus vaccine, (DTaP-IPV/Hib), for intramuscular use |